Skip to main content
Top
Published in: Journal of Neuroinflammation 1/2023

Open Access 01-12-2023 | Human Alphaherpesvirus 3 | Research

Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin

Authors: Leyla Mohammad, Mathias Fousse, Gentiana Wenzel, Marina Flotats Bastardas, Klaus Faßbender, Ulrich Dillmann, Bernhard Schick, Michael Zemlin, Barbara C. Gärtner, Urban Sester, David Schub, Tina Schmidt, Martina Sester

Published in: Journal of Neuroinflammation | Issue 1/2023

Login to get access

Abstract

Background

Peripheral facial palsy (PFP) is a common neurologic symptom which can be triggered by pathogens, autoimmunity, trauma, tumors, cholesteatoma or further local conditions disturbing the peripheral section of the nerve. In general, its cause is often difficult to identify, remaining unknown in over two thirds of cases. As we have previously shown that the quantity and quality of pathogen-specific T cells change during active infections, we hypothesized that such changes may also help to identify the causative pathogen in PFPs of unknown origin.

Methods

In this observational study, pathogen-specific T cells were quantified in blood samples of 55 patients with PFP and 23 healthy controls after stimulation with antigens from varicella-zoster virus (VZV), herpes-simplex viruses (HSV) or borrelia. T cells were further characterized by expression of the inhibitory surface molecule CTLA-4, as well as markers for differentiation (CD27) and proliferation (Ki67). Pathogen-specific antibody responses were analyzed using ELISA. Results were compared with conventional diagnostics.

Results

Patients with PFP were more often HSV-seropositive than controls (p = 0.0003), whereas VZV- and borrelia-specific antibodies did not differ between groups. Although the quantity and general phenotypical characteristics of antigen-specific T cells did not differ either, expression of CTLA-4 and Ki67 was highly increased in VZV-specific T cells of 9 PFP patients, of which 5 showed typical signs of cutaneous zoster. In the remaining 4 patients, a causal relationship with VZV was possible but remained unclear by clinical standard diagnostics. A similar CTLA-4- and Ki67-expression profile of borrelia-specific T cells was also found in a patient with acute neuroborreliosis.

Discussion

In conclusion, the high prevalence of HSV-seropositivity among PFP-patients may indicate an underestimation of HSV-involvement in PFP, even though HSV-specific T cell characteristics seem insufficient to identify HSV as a causative agent. In contrast, striking alterations in VZV- and borrelia-specific T cell phenotype and function may allow identification of VZV- and borrelia-triggered PFPs. If confirmed in larger studies, antigen-specific immune-phenotyping may have the potential to improve specificity of the clinical diagnosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sun MZ, Oh MC, Safaee M, Kaur G, Parsa AT. Neuroanatomical correlation of the House-Brackmann grading system in the microsurgical treatment of vestibular schwannoma. Neurosurg Focus. 2012;33:E7.CrossRefPubMed Sun MZ, Oh MC, Safaee M, Kaur G, Parsa AT. Neuroanatomical correlation of the House-Brackmann grading system in the microsurgical treatment of vestibular schwannoma. Neurosurg Focus. 2012;33:E7.CrossRefPubMed
3.
go back to reference Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;124:27–30.CrossRefPubMed Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;124:27–30.CrossRefPubMed
4.
go back to reference Kennedy PG. Herpes simplex virus type 1 and Bell’s palsy-a current assessment of the controversy. J Neurovirol. 2010;16:1–5.CrossRefPubMed Kennedy PG. Herpes simplex virus type 1 and Bell’s palsy-a current assessment of the controversy. J Neurovirol. 2010;16:1–5.CrossRefPubMed
5.
go back to reference Papan C, Kremp L, Weiss C, Petzold A, Schroten H, Tenenbaum T. Infectious causes of peripheral facial nerve palsy in children: a retrospective cohort study with long-term follow-up. Eur J Clin Microbiol Infect Dis. 2019;38:2177–84.CrossRefPubMed Papan C, Kremp L, Weiss C, Petzold A, Schroten H, Tenenbaum T. Infectious causes of peripheral facial nerve palsy in children: a retrospective cohort study with long-term follow-up. Eur J Clin Microbiol Infect Dis. 2019;38:2177–84.CrossRefPubMed
6.
go back to reference Jaamaa S, Salonen M, Seppala I, Piiparinen H, Sarna S, Koskiniemi M. Varicella zoster and Borrelia burgdorferi are the main agents associated with facial paresis, especially in children. J Clin Virol. 2003;27:146–51.CrossRefPubMed Jaamaa S, Salonen M, Seppala I, Piiparinen H, Sarna S, Koskiniemi M. Varicella zoster and Borrelia burgdorferi are the main agents associated with facial paresis, especially in children. J Clin Virol. 2003;27:146–51.CrossRefPubMed
7.
go back to reference Furuta Y, Ohtani F, Kawabata H, Fukuda S, Bergstrom T. High prevalence of varicella-zoster virus reactivation in herpes simplex virus-seronegative patients with acute peripheral facial palsy. Clin Infect Dis. 2000;30:529–33.CrossRefPubMed Furuta Y, Ohtani F, Kawabata H, Fukuda S, Bergstrom T. High prevalence of varicella-zoster virus reactivation in herpes simplex virus-seronegative patients with acute peripheral facial palsy. Clin Infect Dis. 2000;30:529–33.CrossRefPubMed
8.
go back to reference Bruinsma RA, Smulders CA, Vermeeren YM, van Kooten B, Cats EA, van Hees B, van Hensbroek MB, Hovius JW, Zomer TP. Acute facial nerve palsy in children in a Lyme disease-endemic area in the Netherlands. Eur J Clin Microbiol Infect Dis. 2021;40:2455–8.CrossRefPubMed Bruinsma RA, Smulders CA, Vermeeren YM, van Kooten B, Cats EA, van Hees B, van Hensbroek MB, Hovius JW, Zomer TP. Acute facial nerve palsy in children in a Lyme disease-endemic area in the Netherlands. Eur J Clin Microbiol Infect Dis. 2021;40:2455–8.CrossRefPubMed
9.
go back to reference Rafati A, Pasebani Y, Jameie M, Yang Y, Jameie M, Ilkhani S, Amanollahi M, Sakhaei D, Rahimlou M, Kheradmand A. Association of SARS-CoV-2 vaccination or infection with bell palsy: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2023;149:493–504.CrossRefPubMedPubMedCentral Rafati A, Pasebani Y, Jameie M, Yang Y, Jameie M, Ilkhani S, Amanollahi M, Sakhaei D, Rahimlou M, Kheradmand A. Association of SARS-CoV-2 vaccination or infection with bell palsy: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2023;149:493–504.CrossRefPubMedPubMedCentral
10.
go back to reference Greco A, Gallo A, Fusconi M, Marinelli C, Macri GF, de Vincentiis M. Bell’s palsy and autoimmunity. Autoimmun Rev. 2012;12:323–8.CrossRefPubMed Greco A, Gallo A, Fusconi M, Marinelli C, Macri GF, de Vincentiis M. Bell’s palsy and autoimmunity. Autoimmun Rev. 2012;12:323–8.CrossRefPubMed
12.
go back to reference Jowett N, Gaudin RA, Banks CA, Hadlock TA. Steroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomes. Laryngoscope. 2017;127:1451–8.CrossRefPubMed Jowett N, Gaudin RA, Banks CA, Hadlock TA. Steroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomes. Laryngoscope. 2017;127:1451–8.CrossRefPubMed
13.
go back to reference Avellan S, Bremell D. Adjunctive corticosteroids for lyme neuroborreliosis peripheral facial palsy: a prospective study with historical controls. Clin Infect Dis. 2021;73:1211–5.CrossRefPubMed Avellan S, Bremell D. Adjunctive corticosteroids for lyme neuroborreliosis peripheral facial palsy: a prospective study with historical controls. Clin Infect Dis. 2021;73:1211–5.CrossRefPubMed
14.
go back to reference de Almeida JR, Al Khabori M, Guyatt GH, Witterick IJ, Lin VY, Nedzelski JM, Chen JM. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA. 2009;302:985–93.CrossRefPubMed de Almeida JR, Al Khabori M, Guyatt GH, Witterick IJ, Lin VY, Nedzelski JM, Chen JM. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA. 2009;302:985–93.CrossRefPubMed
15.
go back to reference Gupta S, Mends F, Hagiwara M, Fatterpekar G, Roehm PC. Imaging the facial nerve: a contemporary review. Radiol Res Pract. 2013;2013: 248039.PubMedPubMedCentral Gupta S, Mends F, Hagiwara M, Fatterpekar G, Roehm PC. Imaging the facial nerve: a contemporary review. Radiol Res Pract. 2013;2013: 248039.PubMedPubMedCentral
16.
go back to reference Happe S, Bunten S. Electrical and transcranial magnetic stimulation of the facial nerve: diagnostic relevance in acute isolated facial nerve palsy. Eur Neurol. 2012;68:304–9.CrossRefPubMed Happe S, Bunten S. Electrical and transcranial magnetic stimulation of the facial nerve: diagnostic relevance in acute isolated facial nerve palsy. Eur Neurol. 2012;68:304–9.CrossRefPubMed
17.
go back to reference Henkel K, Lange P, Eiffert H, Nau R, Spreer A. Infections in the differential diagnosis of Bell’s palsy: a plea for performing CSF analysis. Infection. 2017;45:147–55.CrossRefPubMed Henkel K, Lange P, Eiffert H, Nau R, Spreer A. Infections in the differential diagnosis of Bell’s palsy: a plea for performing CSF analysis. Infection. 2017;45:147–55.CrossRefPubMed
18.
go back to reference Zimmermann J, Jesse S, Kassubek J, Pinkhardt E, Ludolph AC. Differential diagnosis of peripheral facial nerve palsy: a retrospective clinical, MRI and CSF-based study. J Neurol. 2019;266:2488–94.CrossRefPubMed Zimmermann J, Jesse S, Kassubek J, Pinkhardt E, Ludolph AC. Differential diagnosis of peripheral facial nerve palsy: a retrospective clinical, MRI and CSF-based study. J Neurol. 2019;266:2488–94.CrossRefPubMed
19.
go back to reference Engelborghs S, Niemantsverdriet E, Struyfs H, Blennow K, Brouns R, Comabella M, Dujmovic I, van der Flier W, Frolich L, Galimberti D, et al. Consensus guidelines for lumbar puncture in patients with neurological diseases. Alzheimers Dement (Amst). 2017;8:111–26.CrossRefPubMed Engelborghs S, Niemantsverdriet E, Struyfs H, Blennow K, Brouns R, Comabella M, Dujmovic I, van der Flier W, Frolich L, Galimberti D, et al. Consensus guidelines for lumbar puncture in patients with neurological diseases. Alzheimers Dement (Amst). 2017;8:111–26.CrossRefPubMed
20.
go back to reference Sester U, Presser D, Dirks J, Gärtner BC, Köhler H, Sester M. PD-1 expression and IL-2 loss of cytomegalovirus-specific T cells correlates with viremia and reversible functional anergy. Am J Transplant. 2008;8:1486–97.CrossRefPubMed Sester U, Presser D, Dirks J, Gärtner BC, Köhler H, Sester M. PD-1 expression and IL-2 loss of cytomegalovirus-specific T cells correlates with viremia and reversible functional anergy. Am J Transplant. 2008;8:1486–97.CrossRefPubMed
21.
go back to reference Schub D, Janssen E, Leyking S, Sester U, Assmann G, Hennes P, Smola S, Vogt T, Rohrer T, Sester M, Schmidt T. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection. J Infect Dis. 2015;211:600–12.CrossRefPubMed Schub D, Janssen E, Leyking S, Sester U, Assmann G, Hennes P, Smola S, Vogt T, Rohrer T, Sester M, Schmidt T. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection. J Infect Dis. 2015;211:600–12.CrossRefPubMed
22.
go back to reference Schub D, Fousse M, Fassbender K, Gartner BC, Sester U, Sester M, Schmidt T. CTLA-4-expression on VZV-specific T cells in CSF and blood is specifically increased in patients with VZV related central nervous system infections. Eur J Immunol. 2018;48:151–60.CrossRefPubMed Schub D, Fousse M, Fassbender K, Gartner BC, Sester U, Sester M, Schmidt T. CTLA-4-expression on VZV-specific T cells in CSF and blood is specifically increased in patients with VZV related central nervous system infections. Eur J Immunol. 2018;48:151–60.CrossRefPubMed
23.
go back to reference Schmidt T, Sester M. Detection of antigen-specific T cells based on intracellular cytokine staining using flow-cytometry. Methods Mol Biol. 2013;1064:267–74.CrossRefPubMed Schmidt T, Sester M. Detection of antigen-specific T cells based on intracellular cytokine staining using flow-cytometry. Methods Mol Biol. 2013;1064:267–74.CrossRefPubMed
24.
go back to reference Sester M, Sester U, Gärtner B, Heine G, Girndt M, Mueller-Lantzsch N, Meyerhans A, Köhler H. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation. 2001;71:1287–94.CrossRefPubMed Sester M, Sester U, Gärtner B, Heine G, Girndt M, Mueller-Lantzsch N, Meyerhans A, Köhler H. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation. 2001;71:1287–94.CrossRefPubMed
25.
go back to reference Oya R, Takenaka Y, Imai T, Sato T, Oshima K, Ohta Y, Inohara H. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic hematologic markers of Bell’s Palsy: a meta-analysis. Otol Neurotol. 2019;40:681–7.CrossRefPubMed Oya R, Takenaka Y, Imai T, Sato T, Oshima K, Ohta Y, Inohara H. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic hematologic markers of Bell’s Palsy: a meta-analysis. Otol Neurotol. 2019;40:681–7.CrossRefPubMed
26.
go back to reference Sester M, Sester U, Gärtner B, Kubuschok B, Girndt M, Meyerhans A, Köhler H. Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus. J Virol. 2002;76:3748–55.CrossRefPubMedPubMedCentral Sester M, Sester U, Gärtner B, Kubuschok B, Girndt M, Meyerhans A, Köhler H. Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus. J Virol. 2002;76:3748–55.CrossRefPubMedPubMedCentral
27.
go back to reference Adekambi T, Ibegbu CC, Cagle S, Kalokhe AS, Wang YF, Hu Y, Day CL, Ray SM, Rengarajan J. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response. J Clin Invest. 2015;125:1827–38.CrossRefPubMedPubMedCentral Adekambi T, Ibegbu CC, Cagle S, Kalokhe AS, Wang YF, Hu Y, Day CL, Ray SM, Rengarajan J. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response. J Clin Invest. 2015;125:1827–38.CrossRefPubMedPubMedCentral
28.
go back to reference Korr G, Thamm M, Czogiel I, Poethko-Mueller C, Bremer V, Jansen K. Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control. BMC Infect Dis. 2017;17:471.CrossRefPubMedPubMedCentral Korr G, Thamm M, Czogiel I, Poethko-Mueller C, Bremer V, Jansen K. Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control. BMC Infect Dis. 2017;17:471.CrossRefPubMedPubMedCentral
29.
go back to reference Fu X, Tang L, Wang C, Li M, Wu H, Li J, Ma Q, Yang W. A network meta-analysis to compare the efficacy of steroid and antiviral medications for facial paralysis from Bell s Palsy. Pain Phys. 2018;21:559–69. Fu X, Tang L, Wang C, Li M, Wu H, Li J, Ma Q, Yang W. A network meta-analysis to compare the efficacy of steroid and antiviral medications for facial paralysis from Bell s Palsy. Pain Phys. 2018;21:559–69.
30.
go back to reference Gagyor I, Madhok VB, Daly F, Sullivan F. Antiviral treatment for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2019;9:CD001869.PubMed Gagyor I, Madhok VB, Daly F, Sullivan F. Antiviral treatment for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2019;9:CD001869.PubMed
31.
go back to reference Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B, Davenport RJ, Vale LD, Clarkson JE, Hammersley V, et al. Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med. 2007;357:1598–607.CrossRefPubMed Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B, Davenport RJ, Vale LD, Clarkson JE, Hammersley V, et al. Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med. 2007;357:1598–607.CrossRefPubMed
Metadata
Title
Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin
Authors
Leyla Mohammad
Mathias Fousse
Gentiana Wenzel
Marina Flotats Bastardas
Klaus Faßbender
Ulrich Dillmann
Bernhard Schick
Michael Zemlin
Barbara C. Gärtner
Urban Sester
David Schub
Tina Schmidt
Martina Sester
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2023
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/s12974-023-02933-4

Other articles of this Issue 1/2023

Journal of Neuroinflammation 1/2023 Go to the issue